Cargando…

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Activates Type I Interferon Signals in Lupus Nephritis

Type I interferon (IFN) plays a central role in pathogenesis of systemic lupus erythematosus (SLE); tumor necrosis factor-like weak inducer of apoptosis (TWEAK) has been associated with a pathogenic role in lupus nephritis (LN). Thus we investigated whether TWEAK could induce the activation of type...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Leixi, Liu, Lei, Huang, Jun, Wen, Jian, Yang, Ru, Bo, Lin, Tang, Mei, Zhang, Yi, Liu, Zhichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733219/ https://www.ncbi.nlm.nih.gov/pubmed/29333443 http://dx.doi.org/10.1155/2017/4927376

Ejemplares similares

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-β1 Signaling Pathway
por: Liu, Zhiqin, et al.
Publicado: (2016)

Analysis of TNF-like weak inducer of apoptosis for detecting lupus nephritis
por: Susianti, Hani, et al.
Publicado: (2022)

Anti-TWEAK Antibody Alleviates Renal Interstitial Fibrosis by Increasing PGC-1α Expression in Lupus Nephritis
por: Xue, Leixi, et al.
Publicado: (2021)

Iguratimod alleviates tubulo-interstitial injury in mice with lupus
por: Xue, Leixi, et al.
Publicado: (2022)

The Clinical Characteristics of Leukopenia in Patients with Systemic Lupus Erythematosus of Han Ethnicity in China: A Cross-Sectional Study
por: Lu, Wentian, et al.
Publicado: (2021)

Systemic Lupus Erythematosus Risk Probability Index: ready for routine use? Results from a Chinese cohort
por: Zhang, Lin, et al.
Publicado: (2023)

Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis
por: Yang, Ru, et al.
Publicado: (2016)

Correction: Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis
por: Yang, Ru, et al.
Publicado: (2017)

Utility of the ACR-1997, SLICC-2012 and EULAR/ACR-2019 classification criteria for systemic lupus erythematosus: a single-centre retrospective study
por: Lu, Wentian, et al.
Publicado: (2022)

Diagnostic accuracy of the European League against rheumatism/American College of Rheumatology-2019 versus the Systemic Lupus International Collaborating Clinics-2012 versus the ACR-1997 classification criteria in adult systemic lupus erythematosus: A systematic review and meta-analysis
por: Lu, Wentian, et al.
Publicado: (2022)

Gout in the peri-scapular region manifests as paradoxical low back pain
por: Wang, Gang, et al.
Publicado: (2023)

Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients
por: Liu, Xin-ran, et al.
Publicado: (2023)

Hypertrophic osteoarthropathy
por: Wang, Gang, et al.
Publicado: (2023)

Interferon (IFN)-λ is a potential mediator in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2016)

Toll-like receptors in lupus nephritis
por: Devarapu, Satish Kumar, et al.
Publicado: (2018)

Clinical characteristics of patients under 40 years old with early-onset hyperuricaemia: a retrospective monocentric study in China
por: Zhang, Yi, et al.
Publicado: (2019)

GBP2 acts as a member of the interferon signalling pathway in lupus nephritis
por: Zhang, Yuan, et al.
Publicado: (2022)

Allergic Skin Rash Caused by Iguratimod: A Report of Two Cases
por: Lu, Wentian, et al.
Publicado: (2022)

A Rare Case of Primary Sjogren’s Syndrome Coexisting With Gilbert Syndrome
por: Zhang, Lin, et al.
Publicado: (2023)

Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
por: Jayne, David, et al.
Publicado: (2022)

Seronegative rheumatoid arthritis as the first manifestation of multiple myeloma-associated amyloid arthropathy
por: Wang, Gang, et al.
Publicado: (2023)

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon
Publicado: (1987)

Elucidating the role of TNF-like weak inducer of apoptosis in the pathogenesis of cutaneous lupus
por: Doerner, Jessica, et al.
Publicado: (2014)

Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus?
por: Maziad, Asmaa S. Abu, et al.
Publicado: (2017)

Antinuclear Autoantibodies and Lupus Nephritis in Transgenic Mice Expressing Interferon γ in the Epidermis
por: Seery, John P., et al.
Publicado: (1997)

Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells
por: Castellano, Giuseppe, et al.
Publicado: (2015)

Serum tumor necrosis factor-like weak inducer of apoptosis levels are elevated in schizophrenia
por: Kiliç, Faruk, et al.
Publicado: (2020)

Dysregulated heme oxygenase-1(low) M2-like macrophages augment lupus nephritis via Bach1 induced by type I interferons
por: Kishimoto, Daiga, et al.
Publicado: (2018)

Individualizing Therapy in Lupus Nephritis
por: An, Yu, et al.
Publicado: (2019)

EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice
por: Wu, Lingling, et al.
Publicado: (2021)

Fetal and maternal outcome in patients with active lupus nephritis: comparison between new-onset and pre-existing lupus nephritis
por: Lian, Xing-Ji, et al.
Publicado: (2021)

Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves’ orbital fibroblasts
por: Lee, Sung Jun, et al.
Publicado: (2018)

Mesangial cell: A hub in lupus nephritis
por: Liu, Mengdi, et al.
Publicado: (2022)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese
por: Chen, Ji-Yih, et al.
Publicado: (2018)

Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis
por: Wu, Lingling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_usepn9u1p4ilh09jj0dnfa56li